Stockholders' Equity (Deficit) (Tables)

3 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of change in the number of shares of Class A common stock

The following tables present certain information regarding our stockholders’ equity as of March 31, 2024 and 2023:

	Three Months Ended March 31, 2024
	Common Stock		Additional Paid in Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total
January 1, 2024	$	1	$	1,118	$	680	$	(751)	$	(283)	$	765
Settlement of liability awards	—		65		—		—		—		65
Vesting of RSUs, net of tax withholdings and other	—		(43)		—		—		—		(43)
Purchase of treasury stock	—		—		—		(25)		—		(25)
Stock-based compensation	—		14		—		—		—		14
Net income	—		—		82		—		—		82
Other comprehensive loss	—		—		—		—		(23)		(23)
March 31, 2024	$	1	$	1,154	$	762	$	(776)	$	(306)	$	835

	Three Months Ended March 31, 2023
	Common Stock		Additional Paid in Capital		Accumulated Loss		Treasury Stock		Accumulated Other Comprehensive Loss		Noncontrolling Interest		Total
January 1, 2023	$	1	$	1,370	$	517	$	(580)	$	(318)	$	171	$	1,161
Settlement of liability awards	—		25		—		—		—		—		25
Vesting of RSUs, net of tax withholdings and other	—		(14)		—		—		—		—		(14)
Purchase of treasury stock	—		—		—		(28)		—		—		(28)
Purchase of SciPlay’s Class A common stock	—		(8)		—		—		—		—		(8)
Stock-based compensation	—		15		—		—		—		—		15
Net income	—		—		22		—		—		5		27
Other comprehensive income	—		—		—		—		6		—		6
March 31, 2023	$	1	$	1,388	$	539	$	(608)	$	(312)	$	176	$	1,184

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The following reflects total stock-based compensation expense recognized under all programs:

	Three Months Ended March 31,
	2024		2023
Related to L&W RSUs	$	22	$	19
Related to SciPlay RSUs	—		7
Total(1)	$	22	$	26
(1) Includes $8 million and $11 million of stock-based compensation classified as liability awards as of March 31, 2024 and 2023, respectively.

RSUs outstanding under equity-based compensation plans

A summary of the changes in RSUs outstanding under our equity-based compensation plans during the three months ended March 31, 2024 is presented below:

	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value
Unvested RSUs as of December 31, 2023	2.3	$	55.53
Granted	1.3	$	99.65
Vested	(1.2)	$	73.52
Cancelled	—	$	49.73
Unvested RSUs as of March 31, 2024	2.4	$	71.10